📣 VC round data is live. Check it out!

Universal Vision Valuation Multiples

Discover revenue and EBITDA valuation multiples for Universal Vision and similar public comparables like VieMed, Advanced Technology Company, NIOX Group, CapsoVision and more.

Universal Vision Overview

About Universal Vision

Universal Vision Biotechnology Co Ltd is mainly engaged in operating the business of sales of optical devices, glasses, lenses, and other vision aid products; optometric services; sales and leasing of medical devices; and providing hospital management and technical consultancy services. The company's reportable segments include its Ophthalmology Business segment and the Optometry Business segment. A majority of its revenue is generated from the Ophthalmology Business segment, which is responsible for providing ophthalmic clinics and hospital technical services and consultancy services, and leasing services. The Optometry Business segment is responsible for the sales of glasses and peripheral equipment. Geographically, the company derives maximum revenue from Taiwan and the rest from China.


Founded

1994

HQ

Taiwan

Employees

325

Website

uvb.com.tw

Financials (LTM)

Revenue: $134M
EBITDA: $59M

EV

$328M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Universal Vision Financials

Universal Vision reported last 12-month revenue of $134M and EBITDA of $59M.

In the same LTM period, Universal Vision generated $59M in EBITDA and $34M in net income.

Revenue (LTM)


Universal Vision P&L

In the most recent fiscal year, Universal Vision reported revenue of $134M and EBITDA of $61M.

Universal Vision is profitable as of last fiscal year, with gross margin of 59%, EBITDA margin of 46%, and net margin of 25%.

See analyst estimates for Universal Vision
LTMLast FY202320242025202620272028
Revenue$134M$134M$130M$135M$134M
Gross Profit$79M$78M$81M$79M
Gross Margin59%60%60%59%
EBITDA$59M$61M$57M$59M$61M
EBITDA Margin44%46%44%44%46%
EBIT Margin33%33%32%33%33%
Net Profit$34M$33M$33M$34M$33M
Net Margin25%25%26%25%25%

Financial data powered by Morningstar, Inc.

Universal Vision Stock Performance

Universal Vision has current market cap of $361M, and enterprise value of $328M.

Market Cap Evolution


Universal Vision's stock price is $4.26.

Universal Vision share price decreased by 1.0% in the last 30 days, and by 35.2% in the last year.

Universal Vision has an EPS (earnings per share) of $0.39.

See more trading valuation data for Universal Vision
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$328M$361M-1.6%-1.0%-1.5%-35.2%$0.39

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Universal Vision Valuation Multiples

Universal Vision trades at 2.5x EV/Revenue multiple, and 5.6x EV/EBITDA.

See NTM and 2027E valuation multiples for Universal Vision

EV / Revenue (LTM)


Universal Vision Financial Valuation Multiples

As of May 13, 2026, Universal Vision has market cap of $361M and EV of $328M.

Universal Vision has a P/E ratio of 10.7x.

LTMLast FY202320242025202620272028
EV/Revenue2.5x2.4x2.5x2.4x2.4x
EV/EBITDA5.6x5.4x5.8x5.5x5.4x
EV/EBIT7.5x7.5x7.8x7.3x7.5x
EV/Gross Profit4.1x4.2x4.1x4.1x
P/E10.7x10.8x10.8x10.6x10.8x
EV/FCF11.2x9.3x9.5x8.3x9.3x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Universal Vision Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Universal Vision Margins & Growth Rates

Universal Vision grew revenue by 3% but EBITDA decreased by 1% in the last fiscal year.

In the most recent fiscal year, Universal Vision reported gross margin of 59%, EBITDA margin of 46%, and net margin of 25%.

See estimated margins and future growth rates for Universal Vision

Universal Vision Margins

Last FY202420252026202720282029
Gross Margin59%60%59%
EBITDA Margin46%44%46%44%
EBIT Margin33%33%33%33%
Net Margin25%25%25%26%
FCF Margin26%29%26%14%

Universal Vision Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth3%4%(1%)3%
Gross Profit Growth3%(2%)
EBITDA Growth(1%)4%3%(1%)
EBIT Growth3%6%(2%)3%
Net Profit Growth9%2%(2%)9%
FCF Growth(45%)14%(11%)(45%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Universal Vision Operational KPIs

Universal Vision's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.

Universal Vision's Rule of 40 is 47% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Universal Vision's Rule of X is 51% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Universal Vision
LTMLast FY202320242025202620272028
Rule of 4048%47%
Bessemer Rule of X54%51%
Revenue per Employee$0.4M
Opex per Employee$0.1M
S&M Expenses to Revenue17%17%17%17%
G&A Expenses to Revenue10%10%10%10%
Opex to Revenue26%28%27%26%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Universal Vision Competitors

Universal Vision competitors include VieMed, Advanced Technology Company, NIOX Group, CapsoVision, Coltene, TaiDoc Technology, ClearPoint Neuro, Myriad Genetics, Delcath Systems and Standard BioTools.

Most Universal Vision public comparables operate across Medical Devices, Medical Supplies, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
VieMed1.3x1.3x5.9x5.7x
Advanced Technology Company2.0x154.5x
NIOX Group5.0x5.0x14.8x14.5x
CapsoVision25.6x24.2x(13.9x)
Coltene1.3x1.3x11.1x10.8x
TaiDoc Technology1.8x4.0x
ClearPoint Neuro10.6x9.1x(25.7x)(25.1x)
Myriad Genetics0.6x0.6x12.1x12.2x

This data is available for Pro users. Sign up to see all Universal Vision competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Universal Vision

When was Universal Vision founded?Universal Vision was founded in 1994.
Where is Universal Vision headquartered?Universal Vision is headquartered in Taiwan.
How many employees does Universal Vision have?As of today, Universal Vision has over 325 employees.
Is Universal Vision publicly listed?Yes, Universal Vision is a public company listed on Taipei Exchange.
What is the stock symbol of Universal Vision?Universal Vision trades under 3218 ticker.
When did Universal Vision go public?Universal Vision went public in 2004.
Who are competitors of Universal Vision?Universal Vision main competitors include VieMed, Advanced Technology Company, NIOX Group, CapsoVision, Coltene, TaiDoc Technology, ClearPoint Neuro, Myriad Genetics, Delcath Systems, Standard BioTools.
What is the current market cap of Universal Vision?Universal Vision's current market cap is $361M.
What is the current revenue of Universal Vision?Universal Vision's last 12 months revenue is $134M.
What is the current revenue growth of Universal Vision?Universal Vision revenue growth (NTM/LTM) is 4%.
What is the current EV/Revenue multiple of Universal Vision?Current revenue multiple of Universal Vision is 2.5x.
Is Universal Vision profitable?Yes, Universal Vision is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Universal Vision?Universal Vision's last 12 months EBITDA is $59M.
What is Universal Vision's EBITDA margin?Universal Vision's last 12 months EBITDA margin is 44%.
What is the current EV/EBITDA multiple of Universal Vision?Current EBITDA multiple of Universal Vision is 5.6x.
What is the current FCF of Universal Vision?Universal Vision's last 12 months FCF is $29M.
What is Universal Vision's FCF margin?Universal Vision's last 12 months FCF margin is 22%.
What is the current EV/FCF multiple of Universal Vision?Current FCF multiple of Universal Vision is 11.2x.
How many companies Universal Vision has acquired to date?Universal Vision hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Universal Vision has invested to date?Universal Vision hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Universal Vision

Lists including Universal Vision

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial